Xenomics, Sequenom To Arbitrate $300M Contract Spat
Embattled biotech company Sequenom Inc. has won the dismissal of a $300 million breach of contract suit brought by Xenomics Inc., paving the way for arbitration of Xenomics' claims that Sequenom...To view the full article, register now.
Already a subscriber? Click here to view full article